5 | gamma-Aminobutyric Acid (GABA)IBA
02/2006
-
03/2002 |
4 | LithiumIBA
07/2022
-
10/2018 |
4 | myo-inositol-1 (or 4)-monophosphatase (inositol monophosphatase)IBA
10/2020
-
05/2002 |
3 | 5'-Nucleotidase (5' Nucleotidase)IBA
10/2020
-
05/2002 |
3 | 7- (1,1- dimethylethyl)- 6- (2- ethyl- 2H- 1,2,4- triazol- 3- ylmethoxy)- 3- (2- fluorophenyl)- 1,2,4- triazolo(4,3- b)pyridazineIBA
01/2018
-
01/2009 |
3 | BenzodiazepinesIBA
01/2005
-
03/2002 |
2 | Pregnanolone (Allopregnanolone)IBA
04/2024
-
01/2022 |
2 | brexanoloneIBA
04/2024
-
01/2022 |
2 | NeurosteroidsIBA
04/2024
-
01/2022 |
2 | Inositol (Myoinositol)IBA
07/2022
-
05/2002 |
2 | EnzymesIBA
07/2022
-
05/2002 |
2 | Apolipoprotein E4IBA
01/2019
-
01/2019 |
2 | Zolpidem (Ambien)FDA LinkGeneric
01/2018
-
06/2007 |
2 | Diazepam (Valium)FDA LinkGeneric
01/2018
-
06/2007 |
2 | PoisonsIBA
01/2016
-
06/2014 |
2 | Anti-Anxiety Agents (Anxiolytics)IBA
01/2010
-
05/2005 |
2 | GABA-A Receptors (GABA(A) Receptor)IBA
09/2009
-
06/2007 |
2 | Pentylenetetrazole (Metrazol)IBA
06/2007
-
11/2006 |
2 | Amyloid beta-PeptidesIBA
02/2007
-
10/2006 |
2 | Peptides (Polypeptides)IBA
02/2007
-
05/2006 |
1 | zuranoloneIBA
04/2024 |
1 | Tuberculin (PPD)IBA
04/2024 |
1 | Aminobutyrates (Aminobutyric Acid)IBA
03/2021 |
1 | alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA
01/2020 |
1 | Ionotropic Glutamate ReceptorsIBA
01/2020 |
1 | ApolipoproteinsIBA
01/2019 |
1 | Apolipoproteins E (ApoE)IBA
01/2019 |
1 | Calbindin 1IBA
10/2018 |
1 | Therapeutic UsesIBA
10/2018 |
1 | Phosphatidylinositols (Phosphatidylinositol)IBA
10/2018 |
1 | 8- ethynyl- 6- (2'- pyridine)- 4H- 2,5,10b- triazabenzo(e)azulene- 3- carboxylic acid ethyl esterIBA
01/2018 |
1 | Alprazolam (Xanax)FDA LinkGeneric
01/2018 |
1 | Dihydroxyphenylalanine (Dopa)IBA
10/2014 |
1 | Adenosine (Adenocard)FDA LinkGeneric
10/2014 |
1 | Haloperidol (Haldol)FDA LinkGeneric
10/2014 |
1 | Reserpine (Serpasil)FDA Link
10/2014 |
1 | 2- amino- 8- (2- (4- morpholinyl)ethoxy)- 4- phenyl- 5H- indeno(1,2- d)pyrimidin- 5- oneIBA
10/2014 |
1 | Dopamine D2 Receptor AntagonistsIBA
10/2014 |
1 | Dopamine (Intropin)FDA LinkGeneric
10/2014 |
1 | Levodopa (L Dopa)FDA LinkGeneric
10/2014 |
1 | Glutamic Acid (Glutamate)FDA Link
09/2013 |
1 | Antipsychotic Agents (Antipsychotics)IBA
03/2008 |
1 | 4,2'- difluoro- 5'- (8- fluoro- 7- (1- hydroxy- 1- methylethyl)imidazo(1,2- a)pyridin- 3- yl)biphenyl- 2- carbonitrileIBA
06/2007 |
1 | Anticonvulsants (Antiepileptic Drugs)IBA
06/2007 |
1 | Amyloid Precursor Protein Secretases (beta-Secretase)IBA
02/2007 |
1 | L 655,708IBA
11/2006 |
1 | TriazinesIBA
02/2006 |
1 | PyrimidinesIBA
01/2006 |
1 | 1- (4- chlorophenyl)- 4- piperidin- 1- yl- 1,5- dihydroimidazol- 2- oneIBA
05/2005 |
1 | ocinaplonIBA
05/2005 |
1 | Chloride Channels (Chloride Channel)IBA
03/2002 |
1 | ConvulsantsIBA
03/2002 |